Skip to main content
PMC home page
British Medical Journal (Clinical Research Ed.) logoLink to British Medical Journal (Clinical Research Ed.)
. 1988 Mar 19;296(6625):820–822. doi: 10.1136/bmj.296.6625.820

Malaria chemoprophylaxis in travellers to east Africa: a comparative prospective study of chloroquine plus proguanil with chloroquine plus sulfadoxine-pyrimethamine

S Fogh, A Schapira, I C Bygbjerg, S Jepsen, C H Mordhorst, K Kuijlen, P Ravn, A Rønn, P C Gøtzsche
PMCID: PMC2545106  PMID: 3130927

Abstract

As malaria caused by Plasmodium falciparum has become resistant to chloroquine alternative drug regimens need to be developed. The prophylactic efficacy against malaria and the side effects of chloroquine phosphate 500 mg weekly with proguanil hydrochloride 200 mg daily was compared with the efficacy of chloroquine 500 mg weekly with sulfadoxine 500 mg-pyrimethamine 25 mg weekly in a randomised study of Scandinavian travellers to Kenya and Tanzania during 1984-5. A total of 767 subjects (416 male and 351 female; 384 taking chloroquine phosphate with proguanil hydrochloride and 383 taking chloroquine with sulfadoxine-pyrimethamine) completed a diary on the breakthrough of malaria and the side effects of treatment while taking the drugs. They were also asked to make thick blood films when symptoms like those of malaria occurred, which were sent to and analysed in Denmark. Four subjects taking chloroquine with proguanil hydrochloride and three taking chloroquine with sulfadoxine-pyrimethamine developed falciparum malaria, which was verified microscopically. Side effects were reported by 36 subjects taking chloroquine phosphate with proguanil hydrochloride and 55 taking the other regimen (p=0·043). The side effects of both regimens were generally mild, but the combination of chloroquine phosphate with proguanil hydrochloride is recommended because it results in fewer side effects.

As breakthroughs of malaria occurred at the earliest after seven weeks self treatment should not be recommended for travellers staying only a short time. Thick blood films are useful for diagnosis of suspected cases of malaria, can be prepared by non-specialists in Africa, and can be analysed successfully after long delays.

Full text

PDF
820

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Black R. H. Malaria in the Australian army in South Vietnam: successful use of a proguanil-dapsone combination for chemoprophylaxis of chloroquine-resistant falciparum malaria. Med J Aust. 1973 Jun 30;1(26):1265–1270. doi: 10.5694/j.1326-5377.1973.tb111114.x. [DOI] [PubMed] [Google Scholar]
  2. Bruce-Chwatt L. J., Hutchinson D. B. Maloprim and agranulocytosis. Lancet. 1983 Dec 24;2(8365-66):1487–1488. doi: 10.1016/s0140-6736(83)90825-5. [DOI] [PubMed] [Google Scholar]
  3. Centers for Disease Control (CDC) Revised recommendations for preventing malaria in travelers to areas with chloroquine-resistant Plasmodium falciparum. MMWR Morb Mortal Wkly Rep. 1985 Apr 12;34(14):185-90, 195. [PubMed] [Google Scholar]
  4. Fogh S., Jepsen S., Effersøe P. Chloroquine-resistant Plasmodium falciparum malaria in Kenya. Trans R Soc Trop Med Hyg. 1979;73(2):228–229. doi: 10.1016/0035-9203(79)90220-7. [DOI] [PubMed] [Google Scholar]
  5. Henderson A., Simon J. W., Melia W. Failure of malaria chemoprophylaxis with a proguanil-chloroquine combination in Papua New Guinea. Trans R Soc Trop Med Hyg. 1986;80(5):838–840. doi: 10.1016/0035-9203(86)90398-6. [DOI] [PubMed] [Google Scholar]
  6. Herzog C., Lambert H. P., Maudgal D., Warhurst D. C., Rogers R. J. Pyrimethamine/dapsone resistant falciparum malaria imported from Kenya. Lancet. 1982 May 15;1(8281):1119–1120. doi: 10.1016/s0140-6736(82)92295-4. [DOI] [PubMed] [Google Scholar]
  7. McLarty D. G., Webber R. H., Jaatinen M., Kihamia C. H., Murru M., Kumano M., Aubert B., Magnuson L. W. Chemoprophylaxis of malaria in non-immune residents in Dar es Salaam, Tanzania. Lancet. 1984 Sep 22;2(8404):656–659. doi: 10.1016/s0140-6736(84)91223-6. [DOI] [PubMed] [Google Scholar]
  8. Milhous W. K., Weatherly N. F., Bowdre J. H., Desjardins R. E. In vitro activities of and mechanisms of resistance to antifol antimalarial drugs. Antimicrob Agents Chemother. 1985 Apr;27(4):525–530. doi: 10.1128/aac.27.4.525. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Peto T. E., Gilks C. F. Strategies for the prevention of malaria in travellers: comparison of drug regimens by means of risk-benefit analysis. Lancet. 1986 May 31;1(8492):1256–1261. doi: 10.1016/s0140-6736(86)91395-4. [DOI] [PubMed] [Google Scholar]
  10. Schapira A., Bygbjerg I. C., Jepsen S., Flachs H., Bentzon M. W. The susceptibility of Plasmodium falciparum to sulfadoxine and pyrimethamine: correlation of in vivo and in vitro results. Am J Trop Med Hyg. 1986 Mar;35(2):239–245. doi: 10.4269/ajtmh.1986.35.239. [DOI] [PubMed] [Google Scholar]
  11. Schapira A. Concomitant resistance to pyrimethamine and cycloguanil of chloroquine-resistant falciparum malaria from East Africa: an in vitro study of 12 isolates. Trans R Soc Trop Med Hyg. 1984;78(3):359–362. doi: 10.1016/0035-9203(84)90122-6. [DOI] [PubMed] [Google Scholar]
  12. Spencer H. C., Sixsmith D. G., Watkins W. M., Koech D. K., Chulay J. D. In vitro response of Kenyan Plasmodium falciparum to chloroquine in different media. Trans R Soc Trop Med Hyg. 1985;79(1):116–118. doi: 10.1016/0035-9203(85)90252-4. [DOI] [PubMed] [Google Scholar]
  13. Spencer H. C., Watkins W. M., Sixsmith D. G., Koech D. K., Chulay J. D. A new in vitro test for pyrimethamine/sulfadoxine susceptibility of Plasmodium falciparum and its correlation with in vivo resistance in Kenya. Bull World Health Organ. 1984;62(4):615–621. [PMC free article] [PubMed] [Google Scholar]
  14. Stahel E., Degrémont A., Lagler U. Pyrimethamine/sulfadoxine resistant falciparum malaria acquired at Dar es Salaam, Tanzania. Lancet. 1982 May 15;1(8281):1118–1119. doi: 10.1016/s0140-6736(82)92294-2. [DOI] [PubMed] [Google Scholar]
  15. Watkins W. M., Brandling-Bennett A. D., Oloo A. J., Howells R. E., Gilles H. M., Koech D. K. Inadequacy of chlorproguanil 20 mg per week as chemoprophylaxis for falciparum malaria in Kenya. Lancet. 1987 Jan 17;1(8525):125–128. doi: 10.1016/s0140-6736(87)91966-0. [DOI] [PubMed] [Google Scholar]

Articles from British Medical Journal (Clinical research ed.) are provided here courtesy of BMJ Publishing Group

RESOURCES